Biogen Inc.
BIIB · Healthcare · Biotechnology
Updated 27 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #316 of 500 by Iconic Score · #35 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Biogen Inc. (BIIB) is a leading biotechnology company focused on discovering, developing, and delivering innovative therapies for neurological diseases. With a market capitalization of $29.9 billion, Biogen specializes in treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease, positioning itself as a key player in the healthcare sector. The company is recognized for its commitment to advancing science and improving patient outcomes through research and development. Biogen's robust pipeline and strategic collaborations underscore its role in addressing unmet medical needs, making it a significant entity in the biotechnology landscape. Its focus on complex neurological disorders highlights the importance of innovation in healthcare, as these conditions often lack effective treatment options.
IconicOracleAI™ Brief
Biogen Inc. currently holds an Iconic Score of 43, reflecting a moderate brand perception amid mixed market sentiment. The company benefits from strong brand visibility, evidenced by a score of 75/100 from logo analysis, which suggests a recognizable presence. However, recent headlines indicate a cautious atmosphere, with discussions around potential earnings performance and industry comparisons that highlight both optimism and historical disappointments, contributing to the overall sentiment surrounding the brand.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.